Woodline Partners LP

Position in NTLA — Intellia Therapeutics, Inc.

CIK 1784547 San Francisco, CA

Position in NTLA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$2,576,794

+$769,822 QoQ

Shares Held

200,998

0.0% QoQ

Ownership

0.144%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2022

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Woodline Partners LP holds $3,424,016,489 across 189 Biotechnology names. NTLA ranks #140 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	2,506,570	$243,763,932
2	TNGX	Tango Therapeutics, Inc.	8,000,013	$167,360,271
3	PTGX	Protagonist Therapeutics, Inc	1,414,173	$149,053,834
4	QNCX	Quince Therapeutics, Inc.	5,200,000	$105,040,000
5	RCUS	Arcus Biosciences, Inc.	3,777,798	$81,600,436
6	ALNY	Alnylam Pharmaceuticals, Inc.	243,883	$80,693,568
7	SRRK	Scholar Rock Holding Corp	1,500,470	$73,763,105
8	RYTM	Rhythm Pharmaceuticals, Inc.	758,891	$66,000,750

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,576,794	200,998	0.0%	Shares	Sole	2026-05-15
2025-12-31	$1,806,972	200,998	0.0%	Shares	Sole	2026-02-17
2025-09-30	$3,471,235	200,998	-83.5%	Shares	Sole	2025-11-14
2025-06-30	$11,434,857	1,219,068	+4957.1%	Shares	Sole	2025-08-14
2025-03-31	$171,393	24,106	-95.0%	Shares	Sole	2025-05-15
2024-09-30	$9,900,003	481,752	-3.3%	Shares	Sole	2024-11-14
2022-12-31	$17,384,361	498,262	+43.5%	Shares	Sole	2023-02-14
2022-09-30	$19,433,285	347,271	+492.0%	Shares	Sole	2022-11-14
2022-06-30	$3,036,293	58,661	—	Shares	Sole	2022-08-15
No filing history on record for this holder in this stock.